855398-57-1 Usage
General Description
6-oxaspiro [4.5] decan-9-one, also known as 6-oxaspiro [4.5] decane-9-one or carvone, is a chemical compound with the molecular formula C10H14O. It is a cyclic ketone and a member of the spiroketone family. Carvone is found in the essential oils of caraway (Carum carvi) and spearmint (Mentha spicata), and it is responsible for their characteristic aroma and flavor. It is used as a flavoring agent in food and beverages, as well as in the production of perfumes and soaps. Carvone also has potential medicinal properties, including antimicrobial, antifungal, and insecticidal activities, making it a subject of interest in pharmaceutical and agricultural research.
Check Digit Verification of cas no
The CAS Registry Mumber 855398-57-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,5,3,9 and 8 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 855398-57:
(8*8)+(7*5)+(6*5)+(5*3)+(4*9)+(3*8)+(2*5)+(1*7)=221
221 % 10 = 1
So 855398-57-1 is a valid CAS Registry Number.
855398-57-1Relevant articles and documents
FUSED DIHYDROINDAZOLE DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN
-
, (2020/02/14)
The present invention relates to fused dihydroindazole derivatives having pharmacological activity towards the α2δ subunit, in particular the α2δ subunit, of the voltage-gated calcium channel. It also relates to compounds having dual pharmacological activ
Opioid receptor agonists and application thereof
-
Paragraph 0300; 0302; 0309-0312, (2019/01/24)
The invention discloses compounds and salts thereof that can be used as opioid receptor ligands, a preparation method of the compounds, compositions containing the compounds, and a use of the compounds as [mu] opioid receptor agonists; the compounds are used for treatment of [mu] opioid receptor-mediated related diseases, such as pains and pain-related disorders.
DEUTERATED COMPOUNDS FOR TREATING PAIN
-
Paragraph 0052; 0054, (2017/07/06)
The invention provides novel chemical compounds useful for treating pain or a related disease or disorder thereof, and pharmaceutical composition and methods of preparation and use thereof.
